Literature DB >> 29213827

Primary progressive aphasia: classification of variants in 100 consecutive Brazilian cases.

Mirna Lie Hosogi Senaha1, Paulo Caramelli2, Sonia M D Brucki3, Jerusa Smid3, Leonel T Takada4, Claudia S Porto1, Karolina G César4, Maria Niures P Matioli4, Roger T Soares4, Letícia L Mansur1, Ricardo Nitrini5.   

Abstract

Primary progressive aphasia (PPA) is a neurodegenerative clinical syndrome characterized primarily by progressive language impairment. Recently, consensus diagnostic criteria were published for the diagnosis and classification of variants of PPA. The currently recognized variants are nonfluent/agrammatic (PPA-G), logopenic (PPA-L) and semantic (PPA-S).
OBJECTIVE: To analyze the demographic data and the clinical classification of 100 PPA cases.
METHODS: Data from 100 PPA patients who were consecutively evaluated between 1999 and 2012 were analyzed. The patients underwent neurological, cognitive and language evaluation. The cases were classified according to the proposed variants, using predominantly the guidelines proposed in the consensus diagnostic criteria from 2011.
RESULTS: The sample consisted of 57 women and 43 men, aged at onset 67.2±8.1 years (range of between 53 and 83 years). Thirty-five patients presented PPA-S, 29 PPA-G and 16 PPA-L. It was not possible to classify 20% of the cases into any one of the proposed variants.
CONCLUSION: It was possible to classify 80% of the sample into one of the three PPA variants proposed. Perhaps the consensus classification requires some adjustments to accommodate cases that do not fit into any of the variants and to avoid overlap where cases fit more than one variant. Nonetheless, the established current guidelines are a useful tool to address the classification and diagnosis of PPA and are also of great value in standardizing terminologies to improve consistency across studies from different research centers.

Entities:  

Keywords:  agrammatic; clinical consensus; logopenic; primary progressive aphasia; semantic; semantic dementia; variants

Year:  2013        PMID: 29213827      PMCID: PMC5619553          DOI: 10.1590/S1980-57642013DN70100017

Source DB:  PubMed          Journal:  Dement Neuropsychol        ISSN: 1980-5764


INTRODUCTION

Primary progressive aphasia (PPA) is a neurodegenerative clinical syndrome characterized primarily by progressive language impairment. Systematic studies on PPA started after Mesulam[1] published his seminal paper entitled "Slowly progressive aphasia without generalized dementia" in 1982. Indeed, cases reported over the past 100 years by Pick, Déjerine, Sérieux and Rosenfeld, which presented degenerative diseases with language disturbances in the initial phase, would possibly fit current criteria for the condition now recognized as PPA.[2] Intensive research on PPA has been carried out toward gaining a better understanding of several aspects of this syndrome, such as neuroimaging, genetics, neuropathology, clinical and cognitive features. Regarding the clinical characteristics of PPA, numerous investigations have explored the heterogeneity of the linguistic forms of this syndrome. For some years, there have been different visions and controversies about the classification and diagnosis of this syndrome.[3-6] However, more recently, consensus diagnostic criteria were published with the objective of providing a standard approach to the diagnosis of PPA and its classification across multicenter studies, by a group of experienced clinicians and researchers from different centers.[7] The consensus establishes that the classification of PPA variants must be based primarily on the clinical features. Besides the clinical diagnosis (first level), the consensus criteria also establish other two levels for the diagnosis: imaging-supported and definite pathologic diagnosis. The first level is clinical classification, done in two steps. In the first step, it is determined whether the patient has PPA according to inclusion and exclusion criteria based on Mesulam's guidelines[8-9] (Table 1). The second step involves the classification of language disturbance into one of the currently recognized variants: nonfluent/agrammatic (PPA-G), logopenic (PPA-L) and semantic (PPA-S), based on language and speech characteristics. For each variant, there are core and ancillary features for the diagnosis (Table 2).
Table 1

Inclusion and exclusion criteria for PPA diagnosis: based on criteria by Mesulam[8,9] (Gorno-Tempini et al., 2011).[7]

Inclusion: all above criteria must be answered positively
1.Most prominent clinical feature is a language disturbance;
2.The language disturbance is the principal cause of impaired daily living activities;
3.Aphasia should be the most prominent deficit at symptom onset, for the initial phases of the disease.
Exclusion: all above criteria must be answered negatively
1.Pattern of deficits is better accounted for by other nondegenerative nervous system or medical disorders;
2.Cognitive disturbance is a better accounted for by psychiatric diagnosis;
3.Prominent initial episodic memory loss, visual memory and visuospatial impairments;
4.Prominent, initial behavioral disturbance.
Table 2

Guidelines to classify PPA variants according to recommendations in consensus diagnosis criteria (Gorno-Tempini et al., 2011).[7]

PPA-G - Nonfluent/agrammatic variant (also known as progressive nonfluent aphasia)
A.One osf the following core features must be present:
1.Agrammatism in language production;
2.Effortful, halting speech with inconsistent speech sound errors and distortions (apraxia of speech).
B.At least 2 of 3 of the following ancillary features must be present:
1.Impaired comprehension of syntactically complex (non-canonical) sentences;
2.Spared single-word comprehension;
3.Spared object knowledge.
PPA-S - Semantic variant (also known as semantic dementia)
A.Both of the following core features must be present:
1.Impaired object naming;
2.Impaired single-word comprehension.
B.At least 3 of 4 of the following ancillary features must be present:
1.Impaired object knowledge, particularly for low-frequency or low-familiarity items;
2.Surface dyslexia or dysgraphia;
3.Spared repetition;
4.Spared grammaticality and motor aspects of speech.
PPA-L - Logopenic variant (also known as logopenic progressive aphasia)
A.Both of the following core features must be present:
1.Impaired single-word retrieval in spontaneous speech and naming;
2.Impaired repetition of phrases and sentences.
B.At least 3 of 4 of the following ancillary features must be present:
1.Phonological errors (phonemic paraphasias) in spontaneous speech or naming;
2.Spared single-word comprehension and object knowledge;
3.Spared motor speech;
4.Absence of frank agrammatism.
Inclusion and exclusion criteria for PPA diagnosis: based on criteria by Mesulam[8,9] (Gorno-Tempini et al., 2011).[7] Guidelines to classify PPA variants according to recommendations in consensus diagnosis criteria (Gorno-Tempini et al., 2011).[7] The second level of classification, besides the clinical findings of the characteristics of each subtype, includes imaging-supported diagnosis, where the following features must be present on structural or functional neuroimaging: [1] nonfluent/agrammatic variant (PPA-G), predominant left fronto-insular area abnormalities on neuroimaging assessment; [2] semantic variant, predominant anterior temporal lobe atrophy, hypoperfusion or hypometabolism; and [3] logopenic variant, imaging abnormalities predominantly in left posterior perisylvian or parietal areas are necessary. For the third classification level, definite pathologic diagnosis, the consensus establishes that, besides the typical clinical characteristics of each variant, the patient must present pathologic or genetic mutations definitely associated with the frontotemporal lobar degeneration (FTLD) spectrum, Alzheimer's disease (AD), or another specific etiology. Studies have shown that PPA-G is more frequently associated with deposits of hyperphosphorylated tau protein, whereas PPA-S is associated with deposits of ubiquitinated TDP-43 protein, whereas PPA-L is more frequently caused by AD, with beta-amyloid and tau protein parenchymal aggregation and deposition.[10-15] Due to the lack of biological markers, PPA clinical classification into one of the variants may help the clinician in identifying the possible pathologic basis and may also assist in the choice of pharmacological intervention. The aim of the present study was to analyze the demographic data and the clinical classification of 100 consecutive PPA patients evaluated in Brazil.

METHODS

Demographic data from a series of 100 PPA patients consecutively evaluated between 1999 and 2012 were analyzed. All patients underwent neurological examination, neuroimaging assessment and comprehensive cognitive, language and semantic memory evaluation. All patients were submitted to structural (MRI/CT) neuroimaging assessment and/or functional (SPECT/PET scan) neuroimaging assessment. All patients were also submitted to language evaluation by the same speech pathologist (MLHS), which included application of the following tools: communication functional evaluation, aphasia battery tests (Beta MT-86,[16] Boston Diagnostic Aphasia Exam-BDAE,[17] Boston Naming Test,[18] Human Frontier Science Program (HFSP) reading and writing protocols[19] and in some cases additional evaluation (example: tasks of semantic memory battery previously described in other papers).[20-21] To evaluate the core and ancillary criteria for diagnosis of the PPA variants, a number of different tasks were used. The analyses of oral production in spontaneous speech and on the Boston Cookie theft picture description task[17] were employed for syntax assessment. In some cases, there was an additional task of ordering single written words, printed on a separated card, to constitute a correct sentence. Syntactic comprehension was evaluated through matching tasks (sentences-pictures) from the Beta MT-86 protocol.[16] Speech motor disturbances were evaluated from the assessment proposed by Darley et al.[22] Semantic comprehension was evaluated through word-picture matching and word definition tasks from the semantic memory battery.[20-21] The BDAE[17] stimulus were used to assess sentence repetition. Object knowledge (visual semantic memory) was assessed through qualitative analysis of responses on the Boston Naming Test[18] and in some cases the Peno protocol,[23] Pyramids and Palm Tree (PPT)[24] and famous face recognition tests were used.[20,21] Written language abilities were examined through reading aloud and dictation tasks from the HFSP protocol[19] or Beta MT-86 aphasia protocol".[16] From the data obtained in the language evaluation, cases were classified according to the proposed variants, using predominantly the criteria proposed by the consensus[7] (Table 1), but also with support of other studies.[25-28] Besides the 100 consecutive PPA cases included in this study over the 13-year study period, two patients evaluated were diagnosed with progressive apraxia of speech based on current criteria.

RESULTS

The evaluated sample comprised 57 women and 43 men. The main demographic data and Mini-Mental State Examination (MMSE) scores[29,30] are shown in Table 3. Ninety-eight patients were right-handed, one case had a history of developmental dyslexia and two cases had a history of transient global amnesia episodes before the emergence of language disturbance.
Table 3

Demographic data of PPA patients studied.

  Mean (SD)MedianMinimum/maximum values
All PPA patients (n=100; 57 women and 43 men)Age69.8 (8.3)69.554-90
Age at onset67.2 (8.1)67.053-83
Educational level12.5 (4.7)152-20*
Mini-Mental State Exam22.1 (4.8)2311-29**
PPA-S (n=35; 18 women and 17 men)Age69.1 (8.0)68.055-88
Age at onset64.1 (13.6)67.053-82
Educational level13.5 (4.5)153-20
Mini-Mental State Exam21.6 (5.5)2311-29***
PPA-G (n=29; 18 women and 11 men)Age70.1 (8.6)70.057-85
Age at onset68.2 (8.5)68.054-83
Educational level11.4 (4.9)112-20
Mini-Mental State Exam22.2 (5.0)23.511-20****
PPA-L (n=16; 10 women and 6 men)Age67.4 (8.3)68.554-79
Age at onset65.3 (8.5)66.551-77
Educational level13.7 (3.6)155-20
Mini-Mental State Exam20.6 (4.5)2413-29*****

SD, standard deviation;

one case of informal education;

data from 88 cases;

29 cases;

26 cases;

15 cases.

Demographic data of PPA patients studied. SD, standard deviation; one case of informal education; data from 88 cases; 29 cases; 26 cases; 15 cases. Figure 1 shows age distribution at time of diagnosis for the overall sample and for the three main variants. Age at diagnosis ranged from 54 to 90 years. Thirty-four patients had disease onset before 65 years of age.
Figure 1

[A] Distribution of age at diagnosis for all PPA cases. [B] Distribution of age at diagnosis for PPA-S cases. [C] Distribution of age at diagnosis for PPA-G cases. [D] Distribution of age at diagnosis for PPA-L cases.

[A] Distribution of age at diagnosis for all PPA cases. [B] Distribution of age at diagnosis for PPA-S cases. [C] Distribution of age at diagnosis for PPA-G cases. [D] Distribution of age at diagnosis for PPA-L cases. Classification into the PPA variants of the 100 cases can be seen in Figure 2. It was possible to classify 80% of the sample into one of the three PPA variants proposed by the International consensus:[7] 35 presented PPA-S, 29 PPA-G, and 16 PPA-L. Thus, it was not possible to classify 20% of the cases into any one of the proposed variants.

PPA: primary progressive aphasia; PPA-S: semantic variant; PPA-G: nonfluent/agrammatic variant; PPA-L: logopenic variant; PPA-U: unclassifiable; PPA-A: anomic variant; PPA-PWD: pure word deafness variant; PPA-M: mixed variant.[28,29]

PPA: primary progressive aphasia; PPA-S: semantic variant; PPA-G: nonfluent/agrammatic variant; PPA-L: logopenic variant; PPA-U: unclassifiable; PPA-A: anomic variant; PPA-PWD: pure word deafness variant; PPA-M: mixed variant.[28,29] Among these 20 unclassifiable cases, there were six cases of anomic aphasia (PPA-A), three of pure word deafness (PPA-PWD), one case of mixed PPA (PPA-M)[31,32] and ten unclassifiable cases (PPA-U). Table 4 shows the performance on language tasks. Table 5 shows age at onset and at evaluation along with structural and/or functional neuroimaging findings for all PPA cases.
Table 4

Performance on language tasks of PPA patients.

CaseAgrammatism in spontaneous speechMotor speech disordersSemantic comprehensionSyntax comprehension (Montréal-Tolouse MT-86[16])Picture naming (BNT[18])(60 items)FluencySentence repetition (BDAE[17])(16 sentences)Surface dyslexia and/or surface dysgraphia
Word-picture matchingWord definition (13 or 33 items)Sentence-picture matching (38 items)Category (animals)Letter (F, A, S)
PPA-S 1nono65.5% (SMB)53.8% (13)52.6%5 (8.3%)036.8%yes
PPA-S 2nono95.5% (SMB)78.8% (33)100.0%23 (38.3%)102293.8%yes
PPA-S 3nono88.9% (SMB)42.4% (33)97.4%13 (21.7%)51781.3%yes
PPA-S 4nono52.2% (SMB)30.8% (13)97.4%3 (5.0%)2868.8%yes
PPA-S 5nono62.2% (SMB)15.4% (13)97.4%10 (16.7%)52062.5%yes
PPA-S 6nono82.2% (SMB)7.7% (13)100.0%10 (16.7%)42581.2%yes
PPA-S 7nono95.5% (SMB)72.7% (33)100%27 (45.0%)93362.5%yes
PPA-S 8nono96.7% (SMB)57.6% (33)94.7%30 (50.0%)71575.0%yes
PPA-S 9nono82.2% (SMB)NA86.8%3 (5.0%)3716.3%possibly(low education)
PPA-S 10nono64.4% (SMB)30.5% (13)100.0%16 (26.7%)61393.8%yes
PPA-S 11nono92.2% (SMB)72.7% (33)100.0%41 (68.3%)192493.8%yes
PPA-S 12nono85.5% (SMB)69.2% (13)100.0%9 (15.0%)4468.8%yes
PPA-S 13nono55.5% (SMB)30.7% (13)86.8%5 (8.3%)01250.0%foreigner
PPA-S 14nono75.6% (SMB)18.2% (33)100%7 (11.7%)61768.8%yes
PPA-S 15nono73.3% (SMB)NA94.7%5 (8.3%)2450.0%yes
PPA-S 16nono40.0% (SMB)15.1% (33)97.4%4 (6.7%)01287.5%yes
PPA-S 17nono84.4% (SMB)61.5% (13)92.1%21 (35.0%)81781.2%possibly(low education)
PPA-S 18nono71.1% (SMB)NA97.4%5 (8.3%)61375.0%no (intense dyslexia and dysgraphia)
PPA-S 19nono63.3% (SMB)NA76.3%10 (16.7%)1343.8%yes
PPA-S 20nono63.3% (SMB)NA70.2%1 (1.7%)1362.5%yes
PPA-S 21nono85.5% (SMB)NA100.0%9 (15.0%)42287.5%yes
PPA-S 22nono42.2% (SMB)3.0% (33)94.7%5 (8.3%)2975.0%yes
PPA-S 23nono62.5% (SMB)NA81.6%4 (6.7%)11350.0%yes
PPA-S 24nono10.0% (SMB)NA34.2%3 (5.0%)0037.5%yes
PPA-S 25nono87.5% (SMB)46.2% (13)66.7%9 (15.0%)41375.0%yes
PPA-S 26nono98.9% (SMB)78.8% (33)100.0%20 (33.3%)102287.5%yes
PPA-S 27nono76.7% (SMB)57.60%94.7%17 (28.3%)11293.8%yes
PPA-S 28nono93.3% (SMB)60.6% (33)100.0%13 (21.7%)433100.0%yes
PPA-S 29nono62.2% (SMB)46.1% (13)94.7%5 (8.3%)4487.5%yes
PPA-S 30nono92.2% (SMB)30.7% (13)100.0%15 (25.0%)82587.5%yes
PPA-S 31nono65.5% (SMB)NA92.1%6 (10.0%)22143.8%yes
PPA-S 32nono87.7% (SMB)78.8% (33)92.1%32 (53.3%)5693.8%yes
PPA-S 33nono97.8% (SMB)63.6% (33)84.2%27 (45.0%)121487.5%yes
PPA-S 34nono67.7% (SMB)48.5% (33)92.1%16 (26.7%)931100.0%yes
PPA-S 35nono80.0% (SMB)69.7% (33)97.4%32 (53.3%)81875.0%yes
PPA-L 1nono96.7% (SMB)97.0% (33)86.8%43 (71.7%)71775.0%yes
PPA-L 2nono95.4% (MT-86)97.0% (33)86.8%43 (71.7%)71937.5%yes
PPA-L 3nono95.5% (SMB)NA100.0%70/90 (77.8%)*92962.5%yes
PPA-L 4nono100.0% (SMB)93.9% (33)71.1%38 (63.3%)9781.3%no
PPA-L 5nono96.7% (SMB)NA76.3%16 (26.7%)6318.8%no
PPA-L 6nono95.4% (MT-86)NA100.0%54 (90.0%)163068.7%yes
PPA-L 7nono95.5% (SMB)92.3% (13)92.1%32 (58.3%)134575.0%yes
PPA-L 8nono100.0% (SMB)97.0% (33)100.0%42 (70.0%)112687.5%yes
PPA-L 9nono93.3% (SMB)92.3% (13)57.9%33 (55.0%)14266.7%yes
PPA-L 10nono100.0% (SMB)97.0% (33)94.7%57 (95.0%)152562.5%yes
PPA-L 11nono100.0% (MT-86a)NA78.9%11 (18.3%)6525.0%no
PPA-L 12nono96.7% (SMB)97.0% (33)76.3%53 (88.3%)6781.3%no
PPA-L 13nono90.0% (SMB)NA76.3%17 (28.3%)71156.3%no
PPA-L 14nono95.0% (SMB)93.9% (33)78.9%44 (73.3%)5550.0%no
PPA-L 15nono100.0% (MT-86)100.0% (13)52.6%15 (25.0%)31081.3%yes
PPA-L 16nono100.0% (SMB)90.9% (33)65.7%46 (76.7%)11925.0%yes
PPA-G 1noyes92.2% (SMB)NA71.0%21 (35.0%)3612.5%no
PPA-G 2yesno93.3% (SMB)NA86.8%25 (41.7%)4362.5%no
PPA-G 3yesyes81.1% (SMB)NA52.6%25 (41.7%)5156.3%no
PPA-G 4noyes100.0% (MT-86)NA84.2%37 (61.7%)6562.5%no
PPA-G 5yesno93.3% (SMB)100.0% (13)73.7%48 (80.0%)3462.5%yes
PPA-G 6noyes90.0% (SMB)72.7% (33)57.9%39 (65.0%)61787.5%yes
PPA-G 7noyes95.4% (MT-86)NA68.4%15 (25.0%)2431.3%no
PPA-G 8yesyes97.8% (SMB)93.9% (33)57.9%32 (53.3%)8325.0%no
PPA-G 9noyes100.0% (MT-86)NA71.1%40 (66.7%)2956.3%no
PPA-G 10yesyes100.0% (SMB)97.0% (33)92.1%43 (71.7%)142268.8%yes
PPA-G 11noyes95.4% (MT-86)NA92.1%27 (45.0%)6575.0%foreigner
PPA-G 12yesyes95.4% (MT-86)NA84.2%43 (71.7%)71550.0%yes
PPA-G 13yesyes95.4% (MT-86)87.9% (33)89.5%44 (73.3%)142137.5%no
PPA-G 14yesyes100.0% (SMB)NA89.5%30 (50.0%)7NA50.0%foreigner
PPA-G 15yesno95.0% (SMB)75.6% (33)68.4%25 (41.7%)18812.5%no
PPA-G 16yesyes94.1% (SMB)NA55.3%14 (23.3%)3412.5%no
PPA-G 17yesyes98.9% (SMB)81.8% (33)73.7%24 (40.0%)111031.3%yes
PPA-G 18yesyes97.8% (SMB)63.3% (13)50.0%37 (61.7%)3168.8%no
PPA-G 19yesyes100.0% (MT-86)NA92.1%43 (71.7%)8881.3%no
PPA-G 20yesyes100.0% (SMB)NA81.6%30 (50.0%)11175.0%low education
PPA-G 21yesno97.8% (SMB)90.9% (33)76.3%44 (73.3%)1113100.0%**yes
PPA-G 22yesyes88.9% (SMB)NA57.9%17 (28.3%)436.3%no
PPA-G 23yesyes100.0% (SMB)NA76.3%35 (58.3%)3462.5%yes
PPA-G 24noyes91.1% (SMB)72.7% (33)100.0%32 (53.3%)91187.5%no
PPA-G 25yesno95.5% (SMB)NA65.8%26 (43.3%)2175.0%no
PPA-G 26noyes94.4% (SMB)93.9% (33)89.5%34 (56.7%)101552.5%no
PPA-G 27yesno96.7% (SMB)NA100.0%39 (65.0%)815100.0%no
PPA-G 28noyes76.2% (SMB)51.5% (33)68.4%15 (25.0%)3150.0%low education
PPA-G 29yesyes100.0% (SMB)100% (13)84.2%51 (85.0%)13631.3%no
PPA-A 1nono100.0% (SMB)84.8% (33)94.7%43 (71.7%)113393.8%yes
PPA-A 2nono95.4% (MT-86)100.0% (13)100.0%42 (70.0%)917100.0%yes
PPA-A 3nono100.0% (MT-86)NA100.0%16/25 (64.0%)**6NA100.0%**no
PPA-A 4nono96.7% (SMB)NA89.5%48 (80.0%)1431100.0%no
PPA-A 5nono100.0% (SMB)100.0% (33)100.0%39 (65.0%)829100.0%yes
PPA-A 6nono100.0% (MT-86)NA89.5%32 (53.3%)101193.8%no
PPA-M 1yesyes73.3% (SMB)NA89.5%13 (21.7%)8543.8%yes
PPA-PWD 1nono100.0% (SMB)NA100.0%58 (96.7%)124337.5%no
PPA-PWD 2nono100.0% (SMB)NA52.6%49 (81.7%)10140.0%yes
PPA-PWD 3noyes100.0% (MT-86)NA52.6%29 (48.3%)12170.0%no
PPA-U 1nono93.3% (SMB)69.2% (13)84.2%18 (30.0%)51431.3%possibly(low education)
PPA-U 2nono90.9% (MT-86)NA84.2%10 (16.7%)61750.0%possibly(low education)
PPA-U 3nono95.5% (SMB)NA94.7%34 (56.7%)103175.0%yes
PPA-U 4dyssynntaxiano100.0% (SMB)NA86.8%26 (43.3%)84143.8%yes
PPA-U 5nono81.1% (SMB)72.7% (33)73.7%21 (35.0%)41012.5%low education
PPA-U 6jargonno73.3% (SMB)NA44.7%0 (0%)0NA12.5%no
PPA-U 7nono94.4% (SMB)NA76.3%29 (48.3%)3968.8%yes
PPA-U 8nono88.9% (SMB)75.7% (33)76.3%33 (55.0%)61550.0%yes
PPA-U 9nono80.0% (SMB)45.5% (33)63.1%13 (21.7%)3937.5%low education
PPA-U 10jargonno72.2% (SMB)NA57.9%7 (11.7%)1318.8%no

BNT: Boston Naming Test; BDAE: Boston Diagnostic Aphasia Examination; SMB: semantic memory battery; MT-86: Montréal-Tolouse MT-86; NA: data not available;

SMB (semantic memory battery;

MT-86 (Montréal-Tolouse MT-86).

Table 5

Neuroimaging findings, age at onset, and age at evaluation of PPA patients.

CaseAge at onsetAge at evaluationStructural and/or Functional Neuroimaging findings
PPA-S 16166frontotemporal atrophy and hypoperfusion and parietal hypoperfusion, predominantly left
PPA-S 25659left temporal atrophy and hypoperfusion and left perisylvian enlargement
PPA-S 36263anterior temporal hypoperfusion, predominantly right
PPA-S 45762left temporal atrophy
PPA-S 55355temporal atrophy ,predominantly right
PPA-S 66468temporal atrophy, predominantly left
PPA-S 76467no focal atrophy; left temporal hypoperfusion
PPA-S 86465severe left temporal and mild left frontal hypoperfusion
PPA-S 98082left temporal atrophy
PPA-S 107677left frontotemporal hypoperfusion
PPA-S 116667left temporal atrophy and left temporal hypoperfusion with frontal extension
PPA-S 128283left anterior temporal atrophy and left temporal hypoperfusion
PPA-S 137880mild global atrophy ; temporal anterior hypoperfusion, predominantly left
PPA-S 145456anterior temporal atrophy, predominantly left
PPA-S 155759left anterior temporal atrophy
PPA-S 167073anterior temporal atrophy and hypometabolism
PPA-S 176671left temporal atrophy and hypoperfusion
PPA-S 187275anterior temporal atrophy and hypoperfusion, predominantly left
PPA-S 197388left anterior temporal atrophy and hypoperfusion, and mild right frontal hypoperfusion
PPA-S 205358temporal atrophy, predominantly left, and left anterior temporal hypoperfusion with mild frontal extension
PPA-S 216265temporal atrophy, predominantly right
PPA-S 226972anterior temporal and perisylvian atrophy, predominantly left, and left temporal hypoperfusion
PPA-S 236872temporal atrophy, predominantly left, and left frontotemporoparietal hypoperfusion
PPA-S 246267temporal atrophy, predominantly left
PPA-S 257981temporal atrophy, predominantly left, and left temporoparietal hypoperfusion
PPA-S 266469anterior temporal atrophy, predominantly left
PPA-S 276870temporal hypoperfusion, predominantly left
PPA-S 286063left anterior temporal atrophy and left temporal with frontal extension hypoperfusion
PPA-S 296769left temporal atrophy and hypoperfusion
PPA-S 306264left temporal atrophy and temporoparietal hypoperfusion
PPA-S 316365temporal atrophy and hypoperfusion, predominantly left
PPA-S 327578left frontoparietal hypometabolism
PPA-S 336163left anterior temporal atrophy and hypoperfusion
PPA-S 346972anterior temporal and frontal atrophy, predominantly left
PPA-S 357274bilateral anterior temporal and amygdala atrophy, and frontotemporal and cingulate hypoperfusion (R>L)
PPA-L 15761left frontotemporoparietal hypoperfusion and right frontal hypoperfusion
PPA-L 27779no atrophy, superior posterior parietal hypoperfusion
PPA-L 37274lateral ventricle enlargement, left more than right.
PPA-L 46768left superior frontal hypoperfusion
PPA-L 57679left posterior frontal and temporoparietal hypoperfusion
PPA-L 66567left temporal atrophy and hypoperfusion
PPA-L 77778mild global atrophy and left temporal hypometabolism
PPA-L 86971left temporal atrophy and left frontotemporal hypoperfusion
PPA-L 95557no atrophy and left frontal hypoperfusion
PPA-L 106162left temporoparietal hypometabolism
PPA-L 117274predominantly left perisylvian atrophy
PPA-L 126769left temporal atrophy and left frontotemporoparietal and right frontal hypometabolism
PPA-L 135355left temporal and hippocampal atrophy and left frontotemporoparietal hypoperfusion
PPA-L 146669diffuse mild atrophy slightly more evident at left temporal lobe
PPA-L 156062mild left perisylvian atrophy and predominantly left temporoparietal hypoperfusion
PPA-L 165154left hypoperfusion
PPA-G 17376left temporal atrophy and left temporoparietal hypoperfusion
PPA-G 27478left superior parietal hypoperfusion
PPA-G 36568bilateral frontotemporal (inferior and anterior) hypoperfusion
PPA-G 48282lateral ventricle asymmetry, (L>R).
PPA-G 56465right frontal and left parietal hypoperfusion
PPA-G 67074left temporal atrophy and left frontotemporal hypoperfusion
PPA-G 77073right Sylvian fissure enlargement, right frontotemporoparietal hypoperfusion
PPA-G 86162left perisylvian atrophy
PPA-G 96063left frontotemporoparietal hypoperfusion
PPA-G 108182predominantly posterior cortical atrophy
PPA-G 117172mild global atrophy and left temporoparietooccipital hypoperfusion
PPA-G 126870mild cortical atrophy and predominantly right frontal hypoperfusion
PPA-G 135657left temporoparietal atrophy and bilateral parietooccipital hypoperfusion
PPA-G 147177mild cortical atrophy and left temporal hypoperfusion
PPA-G 158385left temporoparietal hypometabolism
PPA-G 168283frontotemporal and hippocampal atrophy, predominantly left, and predominantly left frontal and cingulated hypoperfusion
PPA-G 175860left temporoparietal hypoperfusion
PPA-G 186870cortical atrophy, predominantly left frontotemporal hypoperfusion
PPA-G 195859sulcal and ventricular enlargement (L>R) and left frontal and left temporal (perisylvian) hypoperfusion
PPA-G 207476no focal atrophy (CT)
PPA-G 216767left perisylvian atrophy and predominantly left frontotemporal hypoperfusion
PPA-G 226062fronto-temporal atrophy, predominantly left, and left parietal and mesial temporal hypoperfusion
PPA-G 236769mild left perisylvian atrophy and left anterior cingulated hypoperfusion
PPA-G 247477lateral ventricle enlargement, predominantly left, and left temporoparietal hypoperfusion
PPA-G 255457global atrophy, predominantly left
PPA-G 265961lateral ventricle enlargement (L>R) and temporoparietal hypoperfusion, predominantly left
PPA-G 275859perisylvian atrophy (right more than left) and right frontotemporal hypoperfusion
PPA-G 288182frontotemporal hypoperfusion, predominantly left
PPA-G 296769frontotemporal atrophy; frontoparietotemporal hypoperfusion, predominantly right
PPA-A 16970left temporal hypoperfusion
PPA-A 26464left temporal (perisylvian) atrophy and left temporoparietal (posterior) hypoperfusion
PPA-A 37375left temporal atrophy
PPA-A 47172MRI: no asymmetries, and left medial temporal hypoperfusion
PPA-A 57376temporoparietal hypoperfusion
PPA-A 68384bilateral temporal hypoperfusion
PPA-M 16979global mild atrophy and predominantly left temporoparietal hypoperfusion
PPA-PWD 15963inspecific signals, predominantly left
PPA-PWD 26163no atrophy; right temporoparietal and very mild left superior posterior parietal hypoperfusion
PPA-PWD 36771predominantly frontotemporal atrophy
PPA-U 17172no atrophy; left temporal hypoperfusion
PPA-U 26871mild global atrophy; left more than right hippocampal atrophy, and left temporoparietal hypoperfusion
PPA-U 36975left perisylvian atrophy and left frontotemporoparietal hypoperfusion
PPA-U 46165left temporoparietal atrophy
PPA-U 57175left perisylvian atrophy and bilateral anterior temporal atrophy
PPA-U 68090global atrophy; left frontal hypoperfusion
PPA-U 76767frontotemporal atrophy and hypoperfusion, predominantly left
PPA-U 85556sulcal enlargement on left side, and left parietooccipital hypoperfusion
PPA-U 98384global atrophy and left temporoparietal hypoperfusion
PPA-U 107779left cortical atrophy and left temporal hypoperfusion with frontoparietal extension

Observation: Cases with less than 2-year history of progressive language disturbances were followed and PPA diagnosis confirmed.

Performance on language tasks of PPA patients. BNT: Boston Naming Test; BDAE: Boston Diagnostic Aphasia Examination; SMB: semantic memory battery; MT-86: Montréal-Tolouse MT-86; NA: data not available; SMB (semantic memory battery; MT-86 (Montréal-Tolouse MT-86). Neuroimaging findings, age at onset, and age at evaluation of PPA patients. Observation: Cases with less than 2-year history of progressive language disturbances were followed and PPA diagnosis confirmed.

DISCUSSION

The data reported in this study included a large number of consecutive PPA cases submitted to language evaluation by the same speech pathologist over a period of 13 years. Our sample had higher mean age at onset than that reported in previous studies[10,33-36] and also contained more women.[33,34] Rogalsky et al.[37] suggested that learning disabilities (LD) may constitute a risk factor for PPA. Their results showed that patients with PPA and their first degree relatives had a higher frequency of LD, especially dyslexia, when compared to patients with AD, with behavioral variant of FTLD and to healthy older adults. During history taking, we systematically asked the patient and informant whether the patient had a history of LD, or difficulty with reading or writing during the first years of school. The informant was in most cases the patient's spouse or son/daughter, who clearly had not lived with the patient during this period. We did not investigate whether any of the patients' first-degree relatives had LD. A history of developmental dyslexia was found in only one case. Recently, a possible association between transient global amnesia and PPA was reported.[38,39] The two patients cited in the Nitrini et al.[39] study are included in this sample. Different manifestations of FTLD in its behavioral and language variants frequently occur in the pre-senile phase. FTLD is considered the second most common cause of degenerative dementia after AD in subjects between 45 and 65 years of age, being less prevalent in the elderly.[40-45] However, this association of FTLD and pre-senile onset must be viewed with caution, because some investigators have reported a significant number of FTLD cases with an age of onset beyond 65.[13,46] Indeed, in a demographic study of 100 semantic dementia cases, Hodges et al. verified that the age at diagnosis was over 65 years in 46% of the patients.[13] Considering all three PPA variants defined by the clinical consensus, semantic and nonfluent/agrammatic cases prevailed in our sample with logopenic cases proving less frequent. Studies conducted after the publication of the clinical consensus have presented different proportions of these variants. A very small number of PPA-L cases in relation to other variants were found in the study by Sajjadi et al. with only 4.3% of patients being classified as PPA-L versus 28.3% as PPA-S and 26.1% as PPA-G.[46] In another report by Thompson et al. investigating fluency and agrammatism in PPA, 37 consecutive cases from the Northwestern Cognitive Neurology and Alzheimer Disease Center were recruited between 2007 and 2010 and a smaller number of PPA-S (6) than PPA-G (11) or PPA-L (20) cases was found.[36] Leyton et al. recruited 47 consecutive PPA patients and found 14 PPA-S, 15 PPA-G and 18 PPA-L[15] cases. In another study, conducted prior to the consensus publication and considering only the dichotomy semantic dementia (SD) versus nonfluent progressive aphasia (NFPA), Hodges et al. found a larger number of SD. In the cited study, the authors included all new patients who were examined at the Memory Clinic in Cambridge, UK, between 1990 and 2007.13 Three thousand six-hundred new patients were evaluated and 416 received the diagnosis of focal cortical dementia. Of these 416 cases, 128 received the diagnosis of fronto-temporal dementia (FTD), 110 SD, 66 NFPA, with 36 mixed (mixed aphasic/behavioural cases) and 66 corticobasal syndrome cases. Further studies on the clinical classification of the PPA subtypes using the guidelines of the consensus may determine the real frequency of each variant. Among the three PPA variants, we considered PPA-S and PPA-G to have more consistent profiles in relation to language characteristics. In PPA-S, the word comprehension and anomia due to semantic degradation are the core and necessary symptoms for the diagnosis of this variant. These symptoms are noticeable aspects of the PPA-S profile. In cases of very mild PPA-S, these symptoms may not be so evident, however when more sensitive tasks are used with less familiar stimuli, the diagnosis of this variant is possible. The word-definition task, requiring besides the stimulus categorization, detailed information that defines the lexical item more precisely, was shown to be a more sensitive task than the word-picture matching task (with eight alternatives of the same semantic category) for detecting verbal semantic memory impairment.[21] In addition to the two core symptoms mentioned for the classification and diagnosis of PPA-S, the presence of surface dyslexia and/or surface dysgraphia, ancillary symptoms for the diagnosis of PPA-S, is also very frequent, since this is secondary to the verbal semantic memory impairment. Besides surface dyslexia, some cases who were able to read by lexical processing (without regularization errors), but who could not access the meaning, have been previously described.[47,48] In other words, in this form of dyslexia, called semantic dyslexia, patients can read irregular words correctly but without comprehension.[47] Other symptoms of PPA-S which are not cited in the classification scheme, but may help in the diagnosis of this variant, are: dissociation between semantic and syntactic comprehension, oral production fluency in quantitative terms, greater difficulty on semantic fluency tasks than phonological fluency tasks (for example, FAS) and low score in confrontation naming. The sum of these symptoms, and the interpretation of these linguistic data, resulting from verbal semantic memory impairment facilitate the diagnosis of PPA-S. In our experience, there is a variation related to the concomitance of verbal and nonverbal semantic impairment. The intensity of the nonverbal semantic impairment varied among our cases, independently of verbal semantic impairment intensity.[20,21] Regarding PPA-G, the two core characteristics according to the clinical consensus - agrammatism in language production and speech motor problems - also constitute exclusive symptoms of this variant that allow its identification. However, according to the clinical consensus, these two central characteristics can occur together or separately, allowing different clinical manifestations to be included under the terminology of PPA-G. Therefore, PPA-G can be considered: [1] patient with agrammatism but without speech motor problems; [2] agrammatic patients with speech motor problems; and [3] aphasic patients without agrammatism but with speech motor problems. In our sample, we found 14 patients with both agrammatism and motor speech disorders, six patients with agrammatism only, and nine patients with motor speech disorder but without agrammatism. This subdivision of the nonfluent/agrammatic PPA variant can be useful. In our experience, only patients with motor speech alterations developed, with disease progression, motor syndromes such as corticobasal degeneration or progressive supranuclear palsy (report in press). The more recently recognized variant - PPA-L - has as core symptoms, described in the consensus, characteristics that are not exclusive. The first core feature - impaired single-word retrieval in spontaneous speech and naming - is a characteristic present in all the variants. Anomia is considered a universal symptom of the aphasias. The second core feature of PPA-L - impaired repetition of phrases and sentences - again cannot be considered exclusive to this variant. PPA-G cases can also present difficulties in repetition tasks. This absence of exclusive characteristics for the diagnosis of PPA-L can lead to a classification by exclusion. Our cases that were classified as PPA-L, besides fitting the characteristics in the consensus criteria, also presented the profile of PPA-L described by Gorno-Tempini et al. and by Henry & Gorno-Tempini.[26,27] The diagnosis of PPA-L requires more attention and experience in the identification and recognition of the symptoms which are sometimes less evident. Furthermore, the two core and the ancillary features for classifying PPA-L also allow the inclusion of patients who do not present the specific profile defined by Gorno-Tempini et al. and Henry & Gorno-Tempini.[26,27] For example, in our sample, two unclassifiable cases (PPA-U) fitted the consensus criteria for PPA-L. They had two core features (impaired single-word retrieval and impaired repetition) and three ancillary features (phonemic paraphasias, spared motor speech and absence of agrammatism). However, we preferred to consider them unclassifiable PPA (PPA-U), because their oral production constituted a form of neologistic jargon, similar to the oral expression seen in Wernicke's aphasics. The possibility of diagnostic criteria overlap leading to uncertainties regarding the precision of classification into one of the three variants, was discussed by Mesulam et al.[32] As PPA-L does not have symptoms that are exclusively associated with this variant, we propose that the ancillary criteria "spared motor speech" and "absence of frank agrammatism" should be made core features in addition to those already included in the diagnostic criteria by Gorno-Tempini et al.[7] This change would probably eliminate the possibility of a patient meeting criteria for both PPA-G and PPA-L. "Absence of neologist jargon" could also be included as an ancillary feature. In the PPA clinical consensus report, Gorno-Tempini et al.[7] argue that only a minority of cases present isolated symptoms or mixed characteristics, but with disease progression, the characteristics of one of the proposed variants became clearer, making classification possible. In the present study, after a cross-sectional evaluation, 20% of the cases were found not to fit any of the three variants. Hence, in our study and similarly in other reports,[15,31,32,46] there are patients whose clinical characteristics do not fit the tripartite system proposed by the consensus. Mesulam et al.,[32] in an analysis of 25 patients with early and mild PPA, were able to classify around 80% of the sample into one of the three variants.[32] In the study of Sajjadi et al.[46], in which 46 PPA patients were prospectively studied with the objective of classifying them into subtypes according to the consensus criteria, less than 60% of the sample was classifiable into any one of the PPA variants.[46] By contrast, Leyton et al. classified 96% (45/47) of their PPA patients into one of the three subtypes.[15] Unclassifiable cases could reflect a point during the evolution of the pathological process, and this concern was discussed by the consensus. However, we believe this explanation does not hold for all our unclassifiable cases, and the tripartite system is probably insufficient to classify the clinical and language characteristics of all PPA cases. The follow-up of some of our cases also did not allow us to fit some patients into any of the proposed subtypes. Of the three cases of pure word deafness, two were accompanied longitudinally and presented with syntactic alterations in written production and surface dysgraphia with disease progression. However, we believe that despite the emergence of agrammatism, the most salient and dysfunctional symptom was difficulty in auditory/oral comprehension. Therefore, it would not have been congruent to label these cases as PPA-G, given the subsequent emergence of syntactic alterations with disease progression. Mesulam et al. suggested the existence of a fourth variant of PPA, the mixed subtype (PPA-M), for cases that present syntactic and word comprehension impairment even in early and mild PPA.[31,32] In our sample, only one unclassifiable case presented this PPA-M phenotype. Mesulam et al. also found cases that presented only anomia and suggested the possibility that this clinical form could be a prodromic stage of PPA-S or be another PPA subtype, anomic variant (PPA-A).[32] In our sample, six unclassifiable cases presented only anomia (PPA-A). In the follow-up, one of our cases developed characteristics of the logopenic and semantic variants concomitantly. Follow-up studies can help define and better understand the different variants of PPA. Perhaps, the consensus classification needs some adjustments to accommodate cases that do not fit into any of the variants and to prevent overlap where cases fit more than one variant. Nonetheless, the established current guidelines are a useful tool to address the classification and diagnosis of PPA and are also of great value in standardizing terminologies to improve consistency across studies from different research centers.
  39 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

Review 2.  Primary progressive aphasia--a language-based dementia.

Authors:  M-Marsel Mesulam
Journal:  N Engl J Med       Date:  2003-10-16       Impact factor: 91.245

Review 3.  The core and halo of primary progressive aphasia and semantic dementia.

Authors:  M-Marsel Mesulam; Murray Grossman; Argye Hillis; Andrew Kertesz; Sandra Weintraub
Journal:  Ann Neurol       Date:  2003       Impact factor: 10.422

4.  [Suggestions for utilization of the mini-mental state examination in Brazil].

Authors:  Sonia M D Brucki; Ricardo Nitrini; Paulo Caramelli; Paulo H F Bertolucci; Ivan H Okamoto
Journal:  Arq Neuropsiquiatr       Date:  2003-10-28       Impact factor: 1.420

Review 5.  Primary progressive aphasia.

Authors:  M M Mesulam
Journal:  Ann Neurol       Date:  2001-04       Impact factor: 10.422

6.  Fluent versus nonfluent primary progressive aphasia: a comparison of clinical and functional neuroimaging features.

Authors:  David Glenn Clark; Anthony Charuvastra; Bruce L Miller; Jill S Shapira; Mario F Mendez
Journal:  Brain Lang       Date:  2005-01-07       Impact factor: 2.381

7.  The prevalence and causes of dementia in people under the age of 65 years.

Authors:  R J Harvey; M Skelton-Robinson; M N Rossor
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-09       Impact factor: 10.154

8.  Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study.

Authors:  Sonia M Rosso; Laura Donker Kaat; Timo Baks; Marijke Joosse; Inge de Koning; Yolande Pijnenburg; Daniëlle de Jong; Dennis Dooijes; Wouter Kamphorst; Rivka Ravid; Martinus F Niermeijer; Frans Verheij; H P Kremer; Philip Scheltens; Cornelia M van Duijn; Peter Heutink; John C van Swieten
Journal:  Brain       Date:  2003-07-22       Impact factor: 13.501

9.  Cognition and anatomy in three variants of primary progressive aphasia.

Authors:  Maria Luisa Gorno-Tempini; Nina F Dronkers; Katherine P Rankin; Jennifer M Ogar; La Phengrasamy; Howard J Rosen; Julene K Johnson; Michael W Weiner; Bruce L Miller
Journal:  Ann Neurol       Date:  2004-03       Impact factor: 10.422

10.  The prevalence of frontotemporal dementia.

Authors:  E Ratnavalli; C Brayne; K Dawson; J R Hodges
Journal:  Neurology       Date:  2002-06-11       Impact factor: 9.910

View more
  4 in total

1.  Dynamic Aphasia as a Variant of Frontotemporal Dementia.

Authors:  Adithya Chandregowda; Heather M Clark; Joseph R Duffy; Mary M Machulda; Val J Lowe; Jennifer L Whitwell; Keith A Josephs
Journal:  Cogn Behav Neurol       Date:  2021-12-02       Impact factor: 1.600

2.  Sentence Comprehension in Primary Progressive Aphasia: A Study of the Application of the Brazilian Version of the Test for the Reception of Grammar (TROG2-Br).

Authors:  Maria Teresa Carthery-Goulart; Rosimeire de Oliveira; Isabel Junqueira de Almeida; Aline Campanha; Dayse da Silva Souza; Yossi Zana; Paulo Caramelli; Thais Helena Machado
Journal:  Front Neurol       Date:  2022-05-16       Impact factor: 4.086

Review 3.  Evolution of language assessment in patients with acquired neurological disorders in Brazil.

Authors:  Maria Alice de Mattos Pimenta Parente; Roberta Roque Baradel; Rochele Paz Fonseca; Natalie Pereira; Maria Teresa Carthery-Goulart
Journal:  Dement Neuropsychol       Date:  2014 Jul-Sep

4.  First Symptoms of Primary Progressive Aphasia and Alzheimer's Disease in Brazilian Individuals.

Authors:  Talita Gallas Dos Reis; Thais Helena Machado; Paulo Caramelli; Francisco Scornavacca; Liana Lisboa Fernandez; Bárbara Costa Beber
Journal:  Front Neurol       Date:  2021-06-11       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.